Among these genes, western blot analysis revealed that SAPCD2 levels were reduced in GSK-J4-treated SH-SY5Y and SK-N-BE(2) (Fig. 1B), and 88 (GSE16476) and 498 (GSE62564) NB cases revealed that a high level of SAPCD2 was a strong predictor of a poor outcome (Fig. 1C). Here, SAPCD2 is linked to neuroblastoma.